Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Late Complications Post-SCT

Treatment of solid tumors following allogeneic bone marrow transplantation

Abstract

Second solid tumors are well known late complications after bone marrow transplantation. Treatment strategies are ill defined. We retrospectively evaluated treatment and outcome in a single institution. From August 1974 to July 1996, six solid tumors were observed in five of 387 patients 2 to 13 years after BMT, corresponding to a probability of developing a second solid tumor of 9% (1–17%, 95 CI) at 15 years: these comprised endometrial carcinoma, carcinoma of the thyroid gland, cervical carcinoma, sarcoma of the small intestine, osteosarcoma of the tibia and ovarian carcinoma. All five patients were treated as intensively as they would be without a history of BMT. At last follow-up four of the five patients were alive and without signs of tumor. We postulate that second solid tumors after BMT should be treated as de novo tumors. Early detection based on consequent clinical follow-up of the transplant patients might explain the relatively good outcome. Bone Marrow Transplantation (2000) 25, 895–898.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Armitage J . Bone marrow transplantation New Engl J Med 1994 330: 827–838

    Article  CAS  Google Scholar 

  2. Schmitz N, Gratwohl A, Goldman JM et al. Guidelines for allogeneic and autologous transplantation in haematological diseases, solid tumors and immune disorders Bone Marrow Transplant 1996 17: 471–477

    CAS  PubMed  Google Scholar 

  3. Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation Blood 1996 87: 3633–3639

    CAS  PubMed  Google Scholar 

  4. Tichelli A, Gratwohl A, Uhr M et al. Gesundheitszustand und Spätkomplikationen nach allogener Knochenmarktransplantation Schweiz Med Wschr 1991 121: 1473–1481

    CAS  PubMed  Google Scholar 

  5. Shapiro RS, McClain K, Frizzera G et al. Epstein–Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation Blood 1988 71: 1234–1243

    CAS  PubMed  Google Scholar 

  6. Socié G, Henry-Amar M, Devergie A et al. Malignant diseases after allogeneic bone marrow transplantation: an updated overview Nouv Rev Fr Hemtol 1994 36: (Suppl.I) 75–77

    Google Scholar 

  7. Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia New Engl J Med 1989 321: 784–789

    Article  CAS  Google Scholar 

  8. Kolb HJ, Duell T, Socié G et al. New malignancies in patients surviving more than 5 years after marrow transplantation Blood 1995 86: (Suppl.1) 460a (Abstr.)

    Google Scholar 

  9. Papadopoulos EB, Ladanyi M, Emmanuel D et al. Infusions of donor leukocytes to treat Epstein–Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation New Engl J Med 1994 330: 1185–1191

    Article  CAS  Google Scholar 

  10. Deeg HJ, Socié G . Malignancies after hematopoietic stem cell transplantation: many questions, some answers Blood 1998 91: 1833–1844

    CAS  PubMed  Google Scholar 

  11. Speck B, Gratwohl A, Tichelli A, Nissen C . Knochenmark-transplantation Schweiz Med Wschr 1995 125: 1515–1532

    CAS  PubMed  Google Scholar 

  12. Socié G, Henry-Amar M, Cosset JM et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia Blood 1991 78: 277–279

    PubMed  Google Scholar 

  13. Deeg HJ, Socié G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris Analysis of results in 700 patients Blood 1996 87: 386–392

    CAS  PubMed  Google Scholar 

  14. Atree SV, Crilley PA, Conroy JF et al. Cancer of the esophagus following allogeneic bone marrow transplantation for acute leukemia Am J Clin Oncol 1995 18: 343–347

    Article  CAS  Google Scholar 

  15. Socié G, Henry-Amar M, Devergie A et al. Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia Leuk Lymphoma 1992 7: 419–423

    Article  Google Scholar 

  16. Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancer after bone marrow transplantation New Engl J Med 1997 336, 13: 897–904

    Article  Google Scholar 

  17. Lishner M, Patterson B, Kandel R et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients Cancer 1990 65: 473–476

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the Swiss National Research Foundation, the Swiss Cancer league and the Swiss Foundation for Cancer Research No. 32–52756.97.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Favre-Schmuziger, G., Hofer, S., Passweg, J. et al. Treatment of solid tumors following allogeneic bone marrow transplantation. Bone Marrow Transplant 25, 895–898 (2000). https://doi.org/10.1038/sj.bmt.1702339

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702339

Keywords

This article is cited by

Search

Quick links